Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index ( PROCLIPI ) study
Kevin Molloy, Constanze Jonak, F. J. Sherida H. Woei‐A‐Jin, et al.
British Journal of Dermatology (2019) Vol. 182, Iss. 3, pp. 770-779
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
Elise A. Olsen, Sean Whittaker, Rein Willemze, et al.
Blood (2021) Vol. 140, Iss. 5, pp. 419-437
Open Access | Times Cited: 112
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
Johanna Latzka, Chalid Assaf, M. Bagot, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113343-113343
Open Access | Times Cited: 68
S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): Update 2021
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 4, pp. 537-554
Open Access | Times Cited: 39
Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management
Denis Miyashiro, José Antônio Sanches
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 26
Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study*
Pietro Quaglino, H. Miles Prince, Richard Cowan, et al.
British Journal of Dermatology (2020) Vol. 184, Iss. 4, pp. 722-730
Open Access | Times Cited: 62
Chlormethine gel in combination with other therapies for treatment of mycosis fungoides: a review with patient cases
Marco Ardigò, Neda Nikbakht, Miriam Teoli, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access | Times Cited: 6
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
Ieva Saulīte, Desislava Ignatova, Yun‐Tsan Chang, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 41
Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a systematic review of the literature
Rosanne Ottevanger, Sylvia van Beugen, Andrea W.M. Evers, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 35, Iss. 12, pp. 2377-2387
Open Access | Times Cited: 39
Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator
Rosanne Ottevanger, Sylvia van Beugen, Andrea W.M. Evers, et al.
JAAD International (2022) Vol. 9, pp. 57-64
Open Access | Times Cited: 25
International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies
Belinda A. Campbell, Gábor Dobos, Zahra Haider, et al.
Blood Advances (2023) Vol. 7, Iss. 21, pp. 6639-6647
Open Access | Times Cited: 16
The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T‐cell lymphoma
Julia Scarisbrick, M. Bagot, Pablo L. Ortiz‐Romero
British Journal of Haematology (2020) Vol. 192, Iss. 4, pp. 683-696
Open Access | Times Cited: 33
Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management
Amy Musiek, Kerri E. Rieger, M. Bagot, et al.
Dermatology and Therapy (2021) Vol. 12, Iss. 1, pp. 29-40
Open Access | Times Cited: 31
S2k‐Leitlinie – Kutane Lymphome (ICD10 C82–C86): Update 2021
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 4, pp. 537-555
Open Access | Times Cited: 22
Health‐related quality of life and its influencing factors in patients with primary cutaneous B‐cell lymphomas: A multicentric study in 100 patients
A. E. C. Schirren, John D. Albrecht, Susanne Melchers, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 5, pp. 954-966
Open Access | Times Cited: 4
Identification of subgroups of early-stage mycosis fungoides patients with increased itch and impaired quality of life
Julia Nenonen, Anna H. Winther, Pontus Jonsson, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Mental Health Diagnoses in Patients With Mycosis Fungoides and Potential Impact on Oncologic Outcomes
Jackson Neal Howell, Bayarmaa Mark, David A. Wada, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Rapid and sustained control of itch and reduction in Th2 bias by dupilumab in a patient with Sézary syndrome
Oliver Steck, Nicole Bertschi, Fabian Luther, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 35, Iss. 6, pp. 1331-1337
Closed Access | Times Cited: 32
Recent advances in understanding and managing cutaneous T-cell lymphomas
Patrick M. Brunner, Constanze Jonak, Robert Knobler
F1000Research (2020) Vol. 9, pp. 331-331
Open Access | Times Cited: 31
Radiotherapy in Cutaneous Lymphomas: Recommendations from the EORTC Cutaneous Lymphoma Tumour Group
Khaled Elsayad, Emmanuella Guenova, Chalid Assaf, et al.
European Journal of Cancer (2024) Vol. 212, pp. 115064-115064
Closed Access | Times Cited: 3
Maintenance therapy in patients with mycosis fungoides or Sézary syndrome: A neglected topic
Rudolf Stadler, Julia Scarisbrick
European Journal of Cancer (2020) Vol. 142, pp. 38-47
Closed Access | Times Cited: 25
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion
Emmilia Hodak, Larisa J. Geskin, Emmanuella Guenova, et al.
American Journal of Clinical Dermatology (2022) Vol. 24, Iss. 1, pp. 5-14
Open Access | Times Cited: 16
Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma
Philipp Licht, Volker Mailänder
Cells (2022) Vol. 11, Iss. 3, pp. 328-328
Open Access | Times Cited: 14
Lifestyle, demographic and Skindex measures associated with cutaneous T-cell lymphoma: a single institution cohort study
Morgan Nguyen, Tessa M. LeWitt, Yanzhen Pang, et al.
Archives of Dermatological Research (2022) Vol. 315, Iss. 2, pp. 275-278
Open Access | Times Cited: 13
Survival in Mycosis Fungoides and Sezary Syndrome: How Can We Predict Outcome?
Julia Scarisbrick
Journal of Investigative Dermatology (2020) Vol. 140, Iss. 2, pp. 281-283
Open Access | Times Cited: 20
Mycosis fungoides and Sézary syndrome
Constanze Jonak, Julia Tittes, Patrick M. Brunner, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2021) Vol. 19, Iss. 9, pp. 1307-1334
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top